Engaging Thought Leaders at the Academia/Industry Interface

Connect with VCs, academic innovators and biopharma decision-makers to discover the latest scientific breakthroughs with commercial potential and discuss critical bottlenecks in translation at the 2nd BioCentury Grand Rounds – U.S. in Chicago, IL, June 4-6, 2025 — right after ASCO!

Unlock transformative opportunities as we debate disease biology, therapeutic modalities and enabling technologies with the innovators driving these advancements

Debate with key thought leaders the scientific hurdles and game-changing opportunities in translation

Discover cutting-edge science with commercial potential

Gain industry insights through presentations by emerging biotechs and academic innovators

Schedule partnering meetings with VCs, pharmas and leading academics

Build your portfolios, pipelines and networks at the academia-industry interfaceAdvanced rates end May 9, 2025

Speakers

Luciana Borio, M.D.

Venture Partner

ARCH Venture Partners

Marty Burke, M.D., Ph.D.

Professor of Chemical Innovation

University of Illinois Urbana–Champaign

Stacy Feld

Global Head, External Scientific Innovation

Johnson & Johnson

Shana Kelley

President

Chan Zuckerberg Biohub Chicago

Jon Sedgwick, Ph.D.

SVP & Global Head Discovery

AbbVie

Maziar Zarrehparvar

Fund Advisor

Kurma Partners

What Will I Learn?

Highlights:

Discovering Disease Biology: Emerging understanding in hot disease areas, and exploration of underserved indications yet to take off

Accelerating Therapeutic Modalities: Overcoming the limitations of current modalities, and creating new molecular species

Enabling Technologies, Empowered: The synthesis of engineering and medicine, and the next-generation tools catalyzing new biological discoveries and advances in drug and diagnostic development

Steering Committee

BioCentury's Scientific Advisory Board brings together top leaders from pharma, biotech, venture and academia and serves as a Steering Committee for the Grand Rounds R&D conference.

Amy Abernethy, M.D., Ph.D.

Co-founder

Highlander Health

Noubar Afeyan, Ph.D.

Founder & CEO

Flagship Pioneering

Houman Ashrafian, D.Phil.

EVP of R&D

Sanofi

Kate Bingham

Managing Partner

SV Health Investors

Melissa Bonner, Ph.D.

Chief Scientific Officer

nChroma Bio Inc.

Luciana Borio, M.D.

Venture Partner

ARCH Venture Partners

Why Should I Attend?

BioCentury Grand Rounds is a science-focused meeting bringing together academia, pharma, VC and biotech leaders to address translational bottlenecks and unlock breakthroughs at the academia-industry interface.

Find opportunities in groundbreaking research to build your portfolio and pipelines. Meet the investors and partners who can catalyze the translation of your discoveries into medicines.

Network, partner and debate with:

VCs and PEs
Biopharma R&D and BD&L Leaders
Biotech C-Suite
Academic Innovators
Financial Dealmakers

Share your Story on Stage

Are you a biotech with cutting-edge innovation? Join the Presenting Company Class of 2025 to increase your visibility and drive partnering requests. Limited space - submit your nominations today.

Apply to Present >>

Share your Science

Showcase your cutting-edge translational science to top-tier investors and biopharma executives. Get in the room with the right people who can accelerate the path between your laboratory discoveries and the development of value-creating medicines.

Learn More >>